CD8A and cancer: Indeed, we observed that CD8+ T lymphocytes showed reduced capacity to kill cancer cells after co-culture with ECM-myCAF but not with Detox-iCAF (Fig. 6E), thereby confirming ECM-myCAF-mediated immunosuppression on CD8+ T lymphocyte cytotoxicity.